ROYAL BANK OF CANADA - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 46 filers reported holding NEON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$2,0000.0%770
-47.9%
0.00%
Q4 2019$2,0001,479
+508.6%
0.00%
Q3 2019$0
-100.0%
243
+127.1%
0.00%
Q4 2018$1,000
-50.0%
107
-65.9%
0.00%
Q3 2018$2,0003140.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$46,175,00019.63%
Endurant Capital Management LP 465,650$2,207,0000.87%
HARVARD MANAGEMENT CO INC 505,871$2,398,0000.59%
Partner Investment Management, L.P. 103,596$491,0000.52%
MEITAV INVESTMENT HOUSE LTD 639,465$3,002,0000.20%
Hillhouse Capital Management 399,308$1,893,0000.06%
ArrowMark Colorado Holdings LLC 703,375$3,334,0000.03%
PFM Health Sciences, LP 121,848$578,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 159,200$755,0000.01%
OXFORD ASSET MANAGEMENT LLP 77,024$365,0000.01%
View complete list of NEON THERAPEUTICS INC shareholders